Alan Lipschitz is a Psychiatry physician affiliated with Merck & Co.. OpenAlex indexes 21 publications with 910 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2301 Renaissance Blvd
Rn0320
King Of Prussia, PA 194062772
Telephone
610-787-3384Registry record last updated 15 Sept 2008.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eisai Inc.Program year20241 payment
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- P2‐413: Avagacestat for predementia Alzheimer's disease: Methods and baseline results
Alzheimer s & Dementia
2012 - Low Doses of Controlled-Release Paroxetine in the Treatment of Late-Life Depression
The Journal of Clinical Psychiatry
2008
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Lubiniecki, MD
Merck & Co.
Luther Clark, MD
Merck & Co.
Alfred Saah, MD
Merck & Co.
Keith Kaufman, MD
Merck & Co.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”